Frederic Monosiet
Psychiatry · Sarasota, FLNPI 1528230828
Payments from drug & device makers
Across 457 payments — averaging $22.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Alkermes, Inc.$2K
- Vanda Pharmaceuticals Inc.$1K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Sunovion Pharmaceuticals Inc.$916
- plus $2K from 9 others
What the payments were for
- Food & beverage$10,285100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 59 | $1,872 |
| Alkermes, Inc. | 75 | $1,628 |
| Vanda Pharmaceuticals Inc. | 64 | $1,423 |
| AbbVie(2 entities) | 63 | $1,062 |
| Otsuka America Pharmaceutical, Inc. | 38 | $1,042 |
| Sunovion Pharmaceuticals Inc. | 60 | $916 |
| Johnson & Johnson | 21 | $644 |
| Teva Pharmaceuticals USA, Inc. | 27 | $528 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $494 |
| Lundbeck LLC | 17 | $339 |
| Indivior Inc. | 10 | $164 |
| Axsome Therapeutics, Inc. | 1 | $114 |
| Noven Therapeutics, LLC | 2 | $30 |
| Corium, LLC | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$716
- LYBALVI$457
- ARISTADA$436
- ABILIFY MAINTENA$227
- INVEGA SUSTENNA$150
- INVEGA TRINZA$150
- CAPLYTA$125
- REXULTI$125
- VRAYLAR$119
- Auvelity$114
- ABILIFY ASIMTUFII$114
- ARISTADA INITIO$109
How this compares
$10,304 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 189 | $594,746 |
| VraylarCariprazine Hcl | 53 | $77,254 |
| CaplytaLumateperone Tosylate | 27 | $46,472 |
| Abilify MaintenaAripiprazole | 15 | $42,938 |
| FanaptIloperidone | 13 | $40,040 |
| PerserisRisperidone | 16 | $37,324 |
| VivitrolNaltrexone Microspheres | 14 | $23,744 |
| Clozapine | 134 | $12,881 |
| TrintellixVortioxetine Hydrobromide | 15 | $7,276 |
| TradjentaLinagliptin | 13 | $7,068 |
| Oxcarbazepine | 143 | $5,862 |
| Paliperidone ErPaliperidone | 26 | $4,980 |
| Quetiapine Fumarate | 176 | $4,381 |
| Olanzapine | 140 | $4,193 |
| Fluphenazine Hcl | 23 | $4,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $644 | $594,746189 claims |
| AbbVieVraylar | $1,062 | $77,25453 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $494 | $46,47227 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $1,042 | $42,93815 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $1,423 | $40,04013 claims |
| Indivior Inc.Perseris | $164 | $37,32416 claims |
| Alkermes, Inc.Vivitrol | $1,628 | $23,74414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Sarasota
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.